flucytosine has been researched along with itraconazole in 232 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (4.74) | 18.7374 |
| 1990's | 98 (42.24) | 18.2507 |
| 2000's | 77 (33.19) | 29.6817 |
| 2010's | 40 (17.24) | 24.3611 |
| 2020's | 6 (2.59) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA | 1 |
| Aurbach, U; Cornely, O; Seifert, H; Stefanik, D | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
| Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF | 1 |
| Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 3 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Afeltra, J; Moglioni, AG; Moltrasio, GY; Sarmiento, GP; Vitale, RG | 1 |
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Denning, DW; Hanson, LH; Perlman, AM; Stevens, DA | 1 |
| de Gans, J; Eeftinck Schattenkerk, JK; Portegies, P; Stam, J; Tiessens, G; van Boxtel, CJ; van Ketel, RJ | 1 |
| Cajot, MA; Gosselin, B; Goullard, L; Koussa, A; Marquette, F; Pol, A; Roux, JP; Soots, G; Warembourg, H | 1 |
| Bayles, MA | 1 |
| Van Cutsem, J | 1 |
| Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P | 1 |
| Bava, AJ; Negroni, R | 1 |
| Büchner, T; Roos, N | 1 |
| Lode, H; Schaberg, T | 1 |
| al-Abedeen Jamjoom, Z; al-Hedaithy, S; Jamali, A; Jamjoom, A; Malabarey, T | 1 |
| Lozano, MC; Martín, E; Parras, P | 1 |
| Chotmongkol, V; Sookprasert, A | 1 |
| Kujala, P; Ruutu, P | 1 |
| Cobbs, CG; Dismukes, WE; Lank, KM; Smith, KR | 1 |
| Bolzinger, T; Pradinaud, R | 1 |
| de Pauw, BE; Fibbe, WE; Novakova, I; van der Meer, JW; van't Wout, JW; Verhagen, CA | 1 |
| Shindo, K | 1 |
| Arning, M; Scharf, RE; Schneider, W; Wolf, HH | 1 |
| Andreassian, B; Bouttier, S; Branger, C; Elzaabi, M; Icard, P; Nussaume, O | 1 |
| Burke, J; Johnson, EM; Pracharktam, R; Warnock, DW | 1 |
| Dupont, B | 3 |
| Blancard, A; Goudard, M; Mary, C; Quilici, M; Regli, P | 1 |
| Polak, A | 1 |
| Longman, LP; Martin, MV | 1 |
| Walsh, TJ | 1 |
| Pizzo, A; Walsh, TJ | 1 |
| Ackerbauer, H; Meingassner, JG; Mieth, H | 1 |
| Abbott, AB; Cockayne, A; Hayward, J; Odds, FC | 1 |
| Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
| Borgers, M; Cauwenbergh, G; Vanden Bossche, H | 1 |
| Gehrt, A; Peter, J; Pizzo, PA; Walsh, TJ | 1 |
| Hoeprich, PD | 1 |
| Freedman, AR; Rowe-Jones, JM | 1 |
| Avet-Loiseau, H; Cohen, JY; Harousseau, JL; Mechinaud-Lacroix, F | 1 |
| Hollis, RJ; Messer, SA; Pfaller, MA | 1 |
| Chotmongkol, V; Jitpimolmard, S | 3 |
| Joly, V | 1 |
| Cortet, B; Delcambre, B; Deprez, X; Duquesnoy, B; Flipo, RM; Le Loët, X; Lucet, L; Richard, R | 1 |
| Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G | 1 |
| Bickers, DR | 1 |
| Denning, DW | 1 |
| Appleyard, MN; Hartley, JP; Leake, HA | 1 |
| Cortet, B; Delcambre, B; Deprez, X; Duquesnoy, B; Flipo, RM; Savage, C; Triki, R | 1 |
| Garg, AK; Hamir, Z; Padhye, AA; Sekhon, AS | 1 |
| Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
| Martinez-Suarez, JV; Rodriguez-Tudela, JL | 1 |
| Kume, H; Murase, S | 1 |
| Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH | 1 |
| Berrouane, YF; Hollis, RJ; Pfaller, MA | 1 |
| Ponglertnapakorn, P; Riantawan, P | 1 |
| Bedos, JP; Darras-Joly, C; Gachot, B; Regnier, B; Veber, B; Wolff, M | 1 |
| Love, DN; Malik, R; Medeiros, C; Wigney, DI | 1 |
| Chanock, SJ; Walsh, TJ | 1 |
| Goto, Y; Hashimoto, A; Nagai, H; Nasu, M; Perparim, K; Tashiro, T | 1 |
| Barbarini, G; Barbaro, G; Di Lorenzo, G | 1 |
| Alonso, J; Iglesias, L; Rodriguez-Peralto, JL; Romero, G; Sanchez-Albisua, B; Vanaclocha, F | 1 |
| Callister, SM; Kirk, SM; Lim, LC; Schell, RF | 1 |
| Jones, RN; Messer, S; Pfaller, MA | 1 |
| Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 3 |
| Igari, J; Yamane, N | 1 |
| Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J | 1 |
| Hollis, RJ; Pfaller, MA; Zhang, J | 1 |
| Digranes, A; Lassen, J; Nilsen, K; Sandven, P; Tjade, T | 1 |
| Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK | 1 |
| Cloud, GA; Dismukes, WE; Graybill, JR; Hamill, RJ; Johnson, PC; Kerkering, T; Moskovitz, BL; Powderly, WG; Saag, MS; Sobel, JD; Tuazon, CU; van der Horst, CM | 1 |
| Cheesbrough, JS; Denning, DW; Hood, SV; Mene, A; Moore, CB | 1 |
| Chotmongkol, V; Sukeepaisarncharoen, W; Thavornpitak, Y | 1 |
| Yamaguchi, H | 1 |
| Kauffman, CA; Spiegel, JE; Tiballi, RN; Zarins, LT | 1 |
| Espinel-Ingroff, A | 1 |
| Graybill, JR | 1 |
| Berenguer Berenguer, J | 1 |
| Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
| Gore, SJ; Graybill, JR; Hardin, TC; Summers, KK | 1 |
| Bruno, R; Calderon, W; Filice, G; Malfitano, A; Parisi, A; Patruno, SF; Sacchi, P | 1 |
| Glasmacher, A; Just-Nübling, G; Molitor, E | 1 |
| Seaton, RA | 1 |
| Gould, IM; Kunova, A; Milne, K; Wood, W | 1 |
| Cameron, R; Chryssanthou, E; Johansson, L; Nayeri, F; Söderström, C | 1 |
| Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H | 1 |
| Arikan, S; Chen, Y; Coffman, S; Heffner, T; Lozano-Chiu, M; Messer, SA; Pfaller, MA; Rennie, R; Rex, JH; Sand, C; Wang, J; Yamane, N | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 3 |
| Cambon, M; Condat, P; Fouassier, M; Joly, D; Peigue-Lafeuille, H | 1 |
| Furuta, I; Kuroda, T; Obana, Y; Ohata, T; Yamazumi, T | 1 |
| Johnson, EM; Rogers, TR; Warnock, DW | 1 |
| Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A | 1 |
| Araj, GF; Daher, NK; Tabbarah, ZA | 1 |
| Watanabe, K | 1 |
| Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Barclay, ML; Begg, EJ; Kirkpatrick, CJ | 1 |
| Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K | 1 |
| Cuenca-Estrella, M; Rodríguez-Tudela, JL | 1 |
| Arzeni, D; Barchiesi, F; Caselli, F; Di Francesco, LF; Gallo, D; Giacometti, A; Scalise, G | 1 |
| Azevedo, V; Caligiorne, RB; Carmo, FH; Melillo, PH; Peluso, CP; Resende, MA | 1 |
| East-Innis, A; Fletcher, H; Nicholson, A; Phillip, H; Rainford, L; Williams, NP | 1 |
| Clancy, CJ; Hong Nguyen, M; Wingard, JR | 1 |
| Ciblak, MA; Clayton, GE; Elie, CM; Li, RK | 1 |
| Hartmann, M; Kappe, R; Prariyachatigul, C; Rimek, D; Zimmermann, T | 1 |
| Anndo, T | 1 |
| Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B | 1 |
| Powderly, WG | 1 |
| Abu Jawdeh, L; Akel, S; Bitar, F; Dbaibo, GS; Haidar, R; Mroueh, S; Nuwayri-Salti, N | 1 |
| Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín-Mazuelos, E; Recio, FJ | 1 |
| Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA | 1 |
| Milheiro, A; Pacheco, FA; Vieira, MR | 1 |
| Kämmerer, R; Klempien, I; Kujath, P; Muhl, E | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
| Torres-Rodríguez, JM; Vivas, JR | 1 |
| Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín Mazuelos, E; Quindós, G; Serrano, C; Valverde, A | 1 |
| Ellepola, AN; Samaranayake, LP | 1 |
| Denning, DW; Moore, CB; Mosquera, J; Sharp, A; Warn, PA | 1 |
| Edlind, TD; Smith, WL | 1 |
| Cartelle, M; Cuenca-Estrella, M; Durán, MT; Gil, E; Guerrero, A; Molina, F; Rodríguez-Tudela, JL | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
| Afeltra, J; de Hoog, GS; Rijs, AJ; Verweij, PE; Vitale, RG | 1 |
| Hamdan, JS; Moraes, EM; Prímola, NS | 1 |
| del Palacio, A; Garau, M; Pereiro, M | 1 |
| Barchiesi, F; Bille, J; Chryssanthou, E; Cuenca-Estrella, M; Denning, DW; Donnelly, JP; Dromer, F; Dupont, B; Moore, CB; Rex, JH; Richardson, MD; Rodríguez-Tudela, JL; Sancak, B; Verweij, PE | 1 |
| Fehér, J; Lengyel, G | 1 |
| Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
| Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S | 1 |
| Arechavala, A; Bianchi, MH; Helou, SH; Negroni, R; Petri, N; Robles, AM | 1 |
| Abe, N; Aihara, M; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K | 1 |
| Schwartz, S; Thiel, E | 1 |
| Al Hedaithy, SS; Fotedar, R | 1 |
| Meis, JF; Mouton, JW; Punt, NC; Te Dorsthorst, DT; Verweij, PE | 1 |
| Meis, JF; Mouton, JW; Te Dorsthorst, DT; van den Beukel, CJ; van der Lee, HA; Verweij, PE | 1 |
| Steinbach, WJ | 1 |
| Chen, R; Liao, W; Yao, Z | 1 |
| Braun, JJ; de Blay, F; Pauli, G | 1 |
| Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST | 1 |
| Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
| Candido, RC; Ferreira, JC; Pedroso, RS | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Reed, E; Ribaud, P; Ruhnke, M; Schwartz, S; Thiel, E; Troke, P | 1 |
| Creutzig, U; Groll, AH; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Ritter, J; Schwabe, D; Varwig, D | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
| Carrillo-Muñoz, AJ; Eraso, E; Espinel-Ingroff, A; Quindós, G; Ruesga, M; Villar-Vidal, M | 1 |
| Andes, D; Smith, J | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Abraham, OC; George, IA; John, L; Joseph, V; Karthik, R; Mathews, MS; Sundar, A | 1 |
| Maesaki, S; Tarumoto, N | 1 |
| Cisalpino, PS; da Costa César, G; de Carvalho, IR; dos Anjos Martins, M; Kohler, LM; Santos, DA; Soares, BM | 1 |
| Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
| Krzyściak, P; Macura, AB | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Hai, W; Jianghan, C; Julin, G; Nan, X; Wanqing, L; Xiaojun, W; Yuanjie, Z | 1 |
| Bolden, CB; Iqbal, N; Kuykendall, RJ; Lockhart, SR | 1 |
| Canton, E; Castanheira, M; Cuenca-Estrella, M; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Ghannoum, M; Jones, RN; Lockhart, SR; Martin-Mazuelos, E; Melhem, MS; Ostrosky-Zeichner, L; Pappas, P; Pelaez, T; Peman, J; Pfaller, MA; Rex, J; Szeszs, MW | 1 |
| Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
| Al-Nakeeb, Z; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Sudan, A; Warn, PA | 1 |
| Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
| Murakami, H; Tashiro, M; Tateda, K; Yamaguchi, K; Yoshizawa, S | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Arsić Arsenijević, V; Barać, A; Crnčević Radović, L; Pekmezović, M; Trpković, A | 1 |
| Baroni, Fde A; Cardoso, PH; Martins, Mdos A; Nascimento, DC; Paula, CR; Silva, EG; Szezs, W | 1 |
| Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K | 1 |
| Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J | 1 |
| Molter, CM; Papendick, R; Zuba, JR | 1 |
| Matsumoto, K; Shiga, M; Suenaga, H; Tsukatani, T | 1 |
| Brillowska-Dabrowska, A; Dzierzanowska-Fangrat, K; Gucwa, K; Milewski, S; Naumiuk, L; Romanowska, E; Szweda, P; Wojciechowska-Koszko, I | 1 |
| Li, J; Liu, B; Pan, A; Zhang, L; Zhou, S | 1 |
| He, C; Kang, M; Lei, Y; Xiao, YL; Xie, Y; Zhang, CY | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H | 1 |
| Cen, W; Feng, W; Lv, Y; Ma, Y; Qiao, Z; Wang, Y; Xi, Z; Yang, J | 1 |
| Arsić Arsenijević, V; Delić, S; Hadnadjev, M; Janić, D; Matijašević, J; Medić, D; Minić, P; Nestorović Laban, S; Otašević, S; Savić, I; Vasiljević, Z | 1 |
| Canteros, CE; Córdoba, S; Davel, G; Hevia, A; Isla, G; Szusz, W; Vivot, W | 1 |
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Nishikawa, H; Taniguchi, Y | 1 |
| Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J | 1 |
| Abe, M; Anzawa, K; Futatsuya, T; Hoshino, Y; Mochizuki, T; Shoji, A | 1 |
| Fatahinia, M; Kiasat, N; Mahmoudabadi, AZ; Moslem, M | 1 |
| Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
| Alanio, A; Bailly, E; Bellanger, AP; Bonhomme, J; Botterel, F; Bouchara, JP; Bougnoux, ME; Bourgeois, N; Brun, S; Cassagne, C; Cassaing, S; Chouaki, T; Costa, D; Dalle, F; Dannaoui, E; Debourgogne, A; Delhaes, L; Desbois-Nogard, N; Dupont, D; Durieux, MF; Fekkar, A; Gangneux, JP; Hasseine, L; Houzé, S; Huguenin, A; Lachaud, L; Le Gal, S; Letscher-Bru, V; Mahinc, C; Maubon, D; Mercier, V; Morio, F; Nourrisson, C; Perraud-Cateau, E; Sasso, M; Sendid, B; Yéra, H | 1 |
| Cai, W; Fang, J; Huang, J; Li, J; Lin, L; Lu, S; Zhang, J | 1 |
42 review(s) available for flucytosine and itraconazole
| Article | Year |
|---|---|
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Primary Aspergillus endocarditis. Apropos of a case and review of the international literature].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Drug Therapy, Combination; Endocarditis; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Recurrence; Reoperation | 1992 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections | 1992 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1992 |
[Systemic antifungal drugs].
Topics: Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Mycoses; Rabbits | 1991 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses | 1991 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
The pharmacology of agents used in the treatment of pulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Miconazole | 1986 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
Adjuvant itraconazole in the treatment of destructive sphenoid aspergillosis.
Topics: Adult; Aged; Amphotericin B; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Male; Paranasal Sinus Diseases; Sphenoid Sinus | 1994 |
[Curative treatment of invasive aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Rifampin | 1994 |
[Role of chemoprophylaxis in the prevention of invasive aspergillosis].
Topics: Aerosols; Amphotericin B; Aspergillosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male | 1994 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Treatment of invasive aspergillosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Aspergillosis; Cholesterol Esters; Drug Carriers; Drug Therapy, Combination; Flucytosine; Humans; Immunocompromised Host; Infusions, Intravenous; Itraconazole; Liposomes; Opportunistic Infections; Rifampin | 1994 |
[Aspergillus spondylodiscitis. Apropos of 5 cases].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Discitis; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed | 1993 |
[Antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole | 1995 |
Nosocomial cerebral aspergillosis: a report of 3 cases.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Brain; Cross Infection; Drug Carriers; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Liposomes; Male; Neurosurgery | 1996 |
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles | 1996 |
[Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Quality Control; Saccharomyces cerevisiae | 1997 |
Clinical relevance of antifungal resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses | 1997 |
[Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Clinical Trials as Topic; Cryptococcosis; Fluconazole; Flucytosine; Humans; Immunotherapy; Itraconazole; Meningitis, Cryptococcal; Mice; Multicenter Studies as Topic; Vaccination | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis | 1995 |
Therapeutic drug monitoring of systemic antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Monitoring; Flucytosine; Humans; Itraconazole; Mycoses | 1997 |
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Fluconazole; Flucytosine; Hematologic Diseases; Humans; Itraconazole; Mycoses | 1998 |
The management of cryptococcal meningitis in Papua New Guinea.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Cause of Death; Drug Combinations; Drug Monitoring; Fluconazole; Flucytosine; Humans; Hydrocortisone; Immunocompetence; Intracranial Hypertension; Intracranial Pressure; Itraconazole; Meningitis, Cryptococcal; Multicenter Studies as Topic; Papua New Guinea | 1996 |
[Geotrichum capitatum infection in a neutropenic patient. Apropos of a case and review of the literature].
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Combinations; Fatal Outcome; Flucytosine; Geotrichosis; Humans; Immunocompromised Host; Itraconazole; Leukemia; Male; Middle Aged; Neutropenia; Opportunistic Infections | 1998 |
[Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole; Mycoses | 1998 |
The therapeutic monitoring of antimicrobial agents.
Topics: Aminoglycosides; Anti-Infective Agents; Antifungal Agents; Drug Monitoring; Flucytosine; Humans; Itraconazole; Teicoplanin; Vancomycin | 1999 |
Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biopsy; Bone Marrow Transplantation; Combined Modality Therapy; Dermatomycoses; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Fungi; Humans; Itraconazole; Male; Middle Aged; Skin | 2000 |
Current approach to the acute management of cryptococcal infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV; HIV Infections; Humans; Itraconazole; Lung Diseases, Fungal; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2000 |
[Choice and use of antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Mycoses; Time Factors | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses | 2003 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
10 trial(s) available for flucytosine and itraconazole
| Article | Year |
|---|---|
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Prospective Studies; Survival Analysis | 1992 |
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Neutropenia; Prospective Studies | 1991 |
Treatment of cryptococcal meningitis with combination itraconazole and flucytosine.
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Female; Flucytosine; Follow-Up Studies; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 1994 |
Treatment of cryptococcal meningitis with triple combination of amphotericin B, flucytosine and itraconazole.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Thailand | 1995 |
Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Double-Blind Method; Drug Therapy, Combination; Esophagitis; Esophagoscopy; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Treatment Outcome | 1996 |
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Multivariate Analysis; Survival Analysis | 1997 |
Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chi-Square Distribution; Cryptococcus neoformans; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged | 1997 |
Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Chronic Disease; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Follow-Up Studies; Humans; Itraconazole; Meningitis, Cryptococcal | 1997 |
Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Central Nervous System Fungal Infections; Child; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Male; Middle Aged; Neuroaspergillosis; Treatment Outcome | 2007 |
Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Itraconazole; Leukemia, Myelomonocytic, Acute; Male; Retrospective Studies | 2007 |
180 other study(ies) available for flucytosine and itraconazole
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.
Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts | 2007 |
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Synthesis and antifungal activity of some substituted phenothiazines and related compounds.
Topics: Antifungal Agents; Drug Discovery; Fungi; Microbial Sensitivity Tests; Phenothiazines; Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Drug Antagonism; Drug Resistance, Microbial; Drug Synergism; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections | 1992 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Female; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycetoma; Mycoses; South Africa; Sporotrichosis | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
Ventriculitis and hydrocephalus caused by Candida albicans successfully treated by antimycotic therapy and cerebrospinal fluid shunting.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Abscess; Candidiasis; Cerebral Ventricles; Cerebrospinal Fluid; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Hydrocephalus; Itraconazole; Ketoconazole; Ventriculoperitoneal Shunt | 1992 |
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity | 1992 |
Itraconazole in cryptococcal meningitis in pregnancy: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Meningitis, Cryptococcal; Pregnancy; Pregnancy Complications, Infectious | 1992 |
In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Therapy, Combination; Echinocandins; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1991 |
Treatment of chromoblastomycosis.
Topics: Antifungal Agents; Chromoblastomycosis; Drug Combinations; Flucytosine; Humans; Itraconazole; Ketoconazole | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged | 1990 |
Preliminary results of treatment with itraconazole in patients with systemic fungal infections.
Topics: Acute Disease; Adult; Agranulocytosis; Antifungal Agents; Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Liver Function Tests; Middle Aged; Mycoses | 1990 |
False aneurysm infected by Aspergillus fumigatus: an unusual complication of aortofemoral bypass graft.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Aorta, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Femoral Artery; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1990 |
Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Interactions; Flucytosine; Itraconazole; Ketoconazole; Methotrexate; Microbial Sensitivity Tests; Spores, Fungal; Time Factors | 1989 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Flucytosine; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Yeasts | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endocarditis; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Rabbits | 1987 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles | 1985 |
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles | 1985 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Colony Count, Microbial; Evaluation Studies as Topic; Flucytosine; Fungi; Fusarium; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests; Mycoses; Pseudallescheria; Rhizopus; Species Specificity | 1995 |
Probable disseminated cerebral aspergillosis: recovery with medical treatment.
Topics: Amphotericin B; Aspergillosis; Brain Diseases; Child; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1994 |
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
Topics: Amphotericin B; Candida; Candidiasis; Cross Infection; DNA, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Karyotyping; Microbial Sensitivity Tests; Molecular Epidemiology | 1995 |
Aspergillus spondylodiscitis: successful conservative treatment in 9 cases.
Topics: Adult; Aged; Amphotericin B; Aspergillosis; Discitis; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunosuppression Therapy; Itraconazole; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Myelography; Retrospective Studies; Spondylitis; Thoracic Vertebrae | 1994 |
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin | 1994 |
Successful treatment of resistant cryptococcal meningitis with amphotericin B lipid emulsion after nephrotoxicity with conventional intravenous amphotericin B.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Drug Resistance, Microbial; Fat Emulsions, Intravenous; Flucytosine; HIV Seropositivity; Humans; Itraconazole; Kidney Diseases; Male; Meningitis, Cryptococcal | 1994 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Penicillium; Phenotype | 1993 |
Treatment of cryptococcal meningitis with short-course amphotericin B and flucytosine, followed by itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged | 1993 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1996 |
In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Peptides | 1996 |
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results | 1996 |
Strain variation among and antifungal susceptibilities of isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Deoxyribonucleases, Type II Site-Specific; DNA, Fungal; Drug Resistance, Microbial; Fluconazole; Flucytosine; Genetic Variation; Humans; Itraconazole; Molecular Epidemiology | 1996 |
Clinical efficacy of itraconazole with initial flucytosine in AIDS-related cryptococcal meningitis: a preliminary study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Drug Therapy, Combination; Female; Flucytosine; Follow-Up Studies; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Prospective Studies; Treatment Outcome | 1996 |
Suspected drug eruption in seven dogs during administration of flucytosine.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Cryptococcosis; Dog Diseases; Dogs; Drug Eruptions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Itraconazole; Male | 1996 |
In vitro susceptibility of Trichosporon beigelii to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon | 1996 |
Cryptococcal cellulitis in an immunocompetent host.
Topics: Aged; Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Dermatomycoses; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Leg Dermatoses | 1997 |
Rapid susceptibility testing of Candida albicans by flow cytometry.
Topics: Acridine Orange; Amphotericin B; Antifungal Agents; Candida albicans; Flow Cytometry; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 1997 |
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles | 1997 |
Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Flucytosine; Gingival Diseases; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Neutropenia | 1997 |
[Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluconazole; Flucytosine; Indicator Dilution Techniques; Itraconazole; Miconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 1997 |
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles | 1997 |
Candida norvegensis: a fluconazole-resistant species.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged | 1997 |
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet | 1996 |
Atypical eumycetoma caused by Phialophora parasitica successfully treated with itraconazole and flucytosine.
Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Female; Flucytosine; Foot Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Phialophora; Soft Tissue Infections | 1997 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens | 1997 |
Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Fatal Outcome; Female; Fluconazole; Flucytosine; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Saccharomyces cerevisiae | 1995 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Comparison of the E test with broth microdilution for antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Yeasts | 1998 |
Candida glabrata prosthesis infection following pyelonephritis and septicaemia.
Topics: Antifungal Agents; Candidiasis; DNA, Fungal; Female; Flucytosine; Hip Prosthesis; Humans; Itraconazole; Middle Aged; Prosthesis-Related Infections; Pyelonephritis; Random Amplified Polymorphic DNA Technique; Sepsis | 1997 |
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Laboratories; Microbial Sensitivity Tests; Quality Control; Time Factors | 1998 |
In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1998 |
[Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Flucytosine; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests | 1998 |
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Evaluation Studies as Topic; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results | 1998 |
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test | 1998 |
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca | 1998 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests | 1998 |
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Drug Combinations; Drug Evaluation; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Leukemia; Lymphoma; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Neutropenia | 1999 |
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic | 1999 |
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Topics: Adult; Age Factors; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Drug Resistance, Microbial; Female; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sex Factors; Spain; Yeasts | 1999 |
In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.
Topics: Antifungal Agents; Colony Count, Microbial; Cryptococcus neoformans; Drug Interactions; Drug Synergism; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests | 1999 |
In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs.
Topics: Antifungal Agents; Chromoblastomycosis; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests | 1999 |
Systemic phaeohyphomycosis in pregnancy and the puerperium.
Topics: Adult; Antifungal Agents; Ascomycota; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Skin; Tomography, X-Ray Computed | 2000 |
Comparison of a new colorimetric assay with the NCCLS broth microdilution method (M-27A) for antifungal drug MIC determination.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2000 |
Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany.
Topics: Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; CD4 Lymphocyte Count; Cross Reactions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Germany; HIV Seropositivity; Humans; Itraconazole; Mycoses; Penicillium; Thailand; Travel | 1999 |
[Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Treatment Outcome | 2000 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2000 |
Aspergillus vertebral osteomyelitis in a child with a primary monocyte killing defect: response to GM-CSF therapy.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Flucytosine; Granulocyte-Macrophage Colony-Stimulating Factor; Histocytochemistry; Humans; Immunocompromised Host; Itraconazole; Leukocyte Count; Magnetic Resonance Imaging; Male; Monocytes; Osteomyelitis; Radiography, Thoracic; Spinal Diseases; Spine; Tomography, X-Ray Computed | 2000 |
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole | 2000 |
Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies | 2000 |
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1999 |
Phaeohyphomycosis due to Cladosporium cladosporioides.
Topics: Adult; Amphotericin B; Antifungal Agents; Cladosporium; Dermatomycoses; Flucytosine; Humans; Itraconazole; Male | 2001 |
[Invasive aspergillosis on a surgical intensive care unit].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi | 2001 |
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis, Oral; Capsules; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cohort Studies; Fluconazole; Flucytosine; Gingival Diseases; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Leukocyte Count; Neutropenia; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Treatment Outcome | 2002 |
Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests | 2002 |
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2002 |
Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
Topics: Amphotericin B; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; DNA-Binding Proteins; Enzyme Inhibitors; Flucytosine; Fungal Proteins; Gene Expression Regulation, Fungal; Histone Deacetylase Inhibitors; Hydroxamic Acids; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Naphthalenes; Sterols; Terbinafine; Transcription Factors; Up-Regulation | 2002 |
[Pseudozyma sp.: colonizer of the respiratory tract in critical patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Critical Care; Female; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Spain; Trichosporon | 2003 |
In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Drug Combinations; Exophiala; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Quinolones; Sulfadiazine | 2003 |
Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus neoformans; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Time Factors | 2003 |
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2003 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EU
Topics: Advisory Committees; Antifungal Agents; Candida; Europe; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Reproducibility of Results | 2003 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.
Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Triazoles | 2004 |
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Random Amplified Polymorphic DNA Technique; Time Factors | 2003 |
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping | 2004 |
In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Interactions; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Models, Biological | 2004 |
Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Flucytosine; Humans; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests | 2004 |
Management of cryptococcosis in non-HIV-related patients.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Child; Child, Preschool; China; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Spinal; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Retrospective Studies; Skin Diseases; Treatment Outcome; Triazoles | 2005 |
[Allergic fungal sinusitis and allergic broncho-pulmonary aspergillosis: a fortuitous association or a nosological rhino-bronchial entity?].
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Endoscopy; Female; Flucytosine; Follow-Up Studies; Humans; Immunoglobulin E; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Prednisolone; Respiratory Hypersensitivity; Retrospective Studies; Sinusitis; Time Factors; Treatment Outcome | 2005 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2006 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candida; Colony Count, Microbial; False Positive Reactions; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reagent Strips; Reproducibility of Results | 2008 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Fatal cerebral abscess caused by Cladophialophora bantiana.
Topics: Adult; Amphotericin B; Antifungal Agents; Ascomycota; Brain Abscess; Central Nervous System Fungal Infections; Cladosporium; Craniotomy; Drug Therapy, Combination; Fatal Outcome; Flucytosine; Humans; Itraconazole; Male | 2008 |
Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Child; Cryptococcus; Drug Resistance, Multiple, Fungal; Drug Synergism; Fluconazole; Flucytosine; Humans; Immunocompetence; Intracranial Hypertension; Itraconazole; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Spinal Puncture; Ventriculoperitoneal Shunt | 2008 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
Drug susceptibility of 64 strains of Rhodotorula sp.
Topics: Amphotericin B; Antifungal Agents; Feces; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Rhodotorula; Skin; Species Specificity; Vagina | 2010 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Cryptococcal meningitis in immunocompetent children.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Child; Child, Preschool; Cryptococcus neoformans; Drug Administration Schedule; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Male; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome | 2012 |
Validation of 24-hour flucytosine MIC determination by comparison with 48-hour determination by the Clinical and Laboratory Standards Institute M27-A3 broth microdilution reference method.
Topics: Antifungal Agents; Candida; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Time Factors | 2011 |
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.
Topics: Amphotericin B; Antifungal Agents; Brazil; Canada; Candida; Candidiasis; Europe; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; United States | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cells, Cultured; Drug Administration Routes; Drug Resistance, Fungal; Flucytosine; Galactose; Humans; Itraconazole; Lung Diseases, Fungal; Mannans; Microbial Sensitivity Tests; Pulmonary Alveoli; Triazoles | 2012 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
[Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].
Topics: Antifungal Agents; Candida; Candidiasis; Diagnosis, Differential; Echinocandins; Feces; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices | 2012 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Kidney Transplantation; Lymphoma; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Postoperative Complications; Serbia | 2012 |
Feline nasal granuloma due to Cryptoccocus gattii type VGII.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Cryptococcosis; Cryptococcus gattii; Flucytosine; Granuloma; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Molecular Diagnostic Techniques; Nose Diseases; Treatment Outcome | 2013 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia | 2014 |
Antifungal susceptibility of Candida isolates at one institution.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole | 2014 |
Cryptococcus gattii osteomyelitis and compounded itraconazole treatment failure in a Pesquet's parrot (Psittrichas fulgidus).
Topics: Animals; Antifungal Agents; Bird Diseases; Cryptococcosis; Cryptococcus gattii; Drug Compounding; Female; Fluconazole; Flucytosine; Itraconazole; Osteomyelitis; Psittaciformes; Treatment Failure | 2014 |
A rapid microplate method for the proliferation assay of fungi and the antifungal susceptibility testing using the colorimetric microbial viability assay.
Topics: Amphotericin B; Antifungal Agents; Candida; Chromogenic Compounds; Colorimetry; Cryptococcus; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Microbial Viability; Oxidation-Reduction; Tetrazolium Salts; Yeasts | 2014 |
Evaluation of possibilities in identification and susceptibility testing for Candida glabrata clinical isolates with the Integral System Yeast Plus (ISYP).
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymerase Chain Reaction; Sensitivity and Specificity | 2014 |
Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Child; Child, Preschool; China; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Infant; Itraconazole; Middle Aged; Voriconazole; Young Adult | 2015 |
[Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].
Topics: Amphotericin B; Antifungal Agents; China; Cryptococcus; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Restriction Fragment Length; Voriconazole | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole | 2016 |
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; RNA, Messenger; Sequence Analysis, DNA; Voriconazole | 2017 |
Candida bloodstream infections in Serbia: First multicentre report of a national prospective observational survey in intensive care units.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Azoles; Candida; Candidemia; Child; Child, Preschool; Female; Flucytosine; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Serbia; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Surveys and Questionnaires; Young Adult | 2018 |
Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
Topics: Animals; Antifungal Agents; Argentina; Calmodulin; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Sequence Analysis, DNA; Soil Microbiology; Sporothrix; Sporotrichosis; Triazoles | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Phaeohyphomycosis Due to
Topics: Aged, 80 and over; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Phaeohyphomycosis; Still's Disease, Adult-Onset; Treatment Outcome | 2019 |
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole | 2020 |
Disseminated cutaneous cryptococcosis in an immunocompetent elderly long-term pigeon fancier.
Topics: Administration, Cutaneous; Aged; Animals; Antifungal Agents; Columbidae; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Skin; Treatment Outcome | 2020 |
Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Genetic Loci; Genetic Variation; Genotype; Imidazoles; Iran; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Voriconazole | 2021 |
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes.
Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Retrospective Studies; Saccharomyces cerevisiae | 2023 |
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China.
Topics: Amphotericin B; Animals; Antifungal Agents; China; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Prevalence; Sporothrix; Sporotrichosis; Terbinafine | 2023 |